1. Carelabs secures Godeok Gangil district land for ₩75.1 Billion! What happened?

Carelabs signed a contract on September 17, 2025, to acquire commercial land in the Godeok Gangil district from the Seoul Housing & Communities Corporation for ₩75.1 billion. This is a significant amount, representing 52.43% of their equity capital. A down payment of ₩7.511 billion was paid on the contract date, with the remaining balance of ₩67.599 billion due on March 13, 2027.

2. Entering the Senior Market: Why now?

Carelabs is pursuing business diversification by entering the senior market, building upon its existing healthcare and beauty care platform business. The high growth potential of the senior market due to the aging population, and the anticipated synergy effects with the existing platform, are analyzed as the background for this investment.

3. Carelabs’ Current Status and Future?

As of the first half of 2025, Carelabs recorded sales of ₩45.587 billion, operating profit of ₩3.416 billion, and net income of ₩24.480 billion, achieving a turnaround to profitability. Total liabilities also decreased, improving financial soundness. This positive trend will act as a supporting factor for this investment. However, the large-scale investment of ₩75.1 billion could create a short-term financial burden, and the intensifying competition in the senior market and macroeconomic volatility are factors that require attention.

4. What should investors do?

This investment is expected to have a positive impact on securing Carelabs’ growth engine in the long term. However, due to the large investment amount and uncertainties associated with entering a new business, investors need to take a cautious approach. It is important to make investment decisions while continuously monitoring Carelabs’ progress in the senior market, financial stability, and market competitiveness.